Molecular pathology of human prion disease

Acta Neuropathologica

Volumn 121, Issue 1, 2011, Pages 69-77

  Wadsworth, Jonathan D F ^a   Collinge, John ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ISOPROTEIN; METHIONINE; PRION PROTEIN;

AMYLOID PLAQUE; BOVINE SPONGIFORM ENCEPHALOPATHY; CANNIBALISM; CLINICAL FEATURE; DISEASE CARRIER; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; DNA POLYMORPHISM; GENE MUTATION; GENETIC CODE; GENETIC STRAIN; HISTOPATHOLOGY; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; IMMUNOBLOTTING; IMMUNOREACTIVITY; KURU; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PHENOTYPIC VARIATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN LOCALIZATION; PUBLIC HEALTH SERVICE; REVIEW; SPORADIC CREUTZFELDT JAKOB DISEASE; STRUCTURE ANALYSIS; TRANSGENICS; VARIANT CREUTZFELDT JAKOB DISEASE; WILD TYPE; ZOONOSIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; HUMANS; PRION DISEASES; PRIONS; PROTEIN ISOFORMS;

EID: 78651252910     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-010-0735-5     Document Type: Review

References (139)

1. A Aguzzi 2003 Prions and the immune system: a journey through gut, spleen, and nerves Adv Immunol 81 123 171 1:CAS:528:DC%2BD2cXhvFaqsrs%3D 14711055 10.1016/S0065-2776(03)81004-0 (Pubitemid 38009043)
2. Alpers MP (1987) Epidemiology and clinical aspects of kuru. In: Prusiner SB, McKinley MP (eds) Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic Press, San Diego, pp 451-465
3. MP Alpers 2008 The epidemiology of kuru: monitoring the epidemic from its peak to its end Philos Trans R Soc Lond B Biol Sci 363 3707 3713 18849286 10.1098/rstb.2008.0071
4. WJ Armitage AB Tullo JW Ironside 2009 Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation Eye 23 1926 1930 1:STN:280:DC%2BD1MnovFykuw%3D%3D 19136921 10.1038/eye.2008.381
5. M Asano S Mohri JW Ironside M Ito N Tamaoki T Kitamoto 2006 vCJD prion acquires altered virulence through trans-species infection Biochem Biophys Res Commun 342 293 299 1:CAS:528:DC%2BD28Xhs1Wlsr4%3D 16480953 10.1016/j.bbrc.2006. 01.149 (Pubitemid 43247390)
6. E Asante J Linehan M Desbruslais, et al. 2002 BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein EMBO J 21 6358 6366 1:CAS:528: DC%2BD38XpsFChtbc%3D 12456643 10.1093/emboj/cdf653 (Pubitemid 35448414)
7. E Asante J Linehan I Gowland, et al. 2006 Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice Proc Natl Acad Sci USA 103 10759 10764 1:CAS:528:DC%2BD28XntFWmsbk%3D 16809423 10.1073/pnas.0604292103 (Pubitemid 44078049)
8. T Baron AG Biacabe JN Arsac S Benestad MH Groschup 2006 Atypical transmissible spongiform encephalopathies (TSEs) in ruminants Vaccine 25 5625 5630 17126958 10.1016/j.vaccine.2006.10.058 1:CAS:528:DC%2BD2sXnslWns74%3D
9. RM Barron SL Campbell D King, et al. 2007 High titres of TSE infectivity associated with extremely low levels of PrPSc in vivo J Biol Chem 282 35878 35886 1:CAS:528:DC%2BD2sXhtlKrsbrO 17923484 10.1074/jbc.M704329200 (Pubitemid 350277109)
10. SL Benestad JN Arsac W Goldmann M Noremark 2008 Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology Vet Res 39 19 18187032 10.1051/vetres:2007056 1:CAS:528:DC%2BD1cXhtFKisb%2FP
11. V Beringue A Le Dur P Tixador, et al. 2008 Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD PLoS One 3 e1419 18183299 10.1371/journal.pone.0001419 1:CAS:528: DC%2BD1cXhtVSms7s%3D (Pubitemid 351223230)
12. V Beringue JL Vilotte H Laude 2008 Prion agents diversity and species barrier Vet Res 39 47 18519020 10.1051/vetres:2008024 1:CAS:528: DC%2BD1cXhtFKisb7K
13. MT Bishop P Hart L Aitchison, et al. 2006 Predicting susceptibility and incubation time of human-to-human transmission of vCJD Lancet Neurol 5 393 398 1:STN:280:DC%2BD283isFWjsA%3D%3D 16632309 10.1016/S1474-4422(06)70413-6
14. A Brachmann U Baxa RB Wickner 2005 Prion generation in vitro: amyloid of Ure2p is infectious EMBO J 24 3082 3092 1:CAS:528:DC%2BD2MXpsleksr8%3D 16096644 10.1038/sj.emboj.7600772 (Pubitemid 41486344)
15. S Brandner J Whitfield K Boone, et al. 2008 Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease Philos Trans R Soc Lond B Biol Sci 363 3755 3763 18849292 10.1098/rstb.2008.0091
16. P Brown F Cathala RF Raubertas DC Gajdusek P Castaigne 1987 The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature Neurology 37 895 904 1:STN:280:DyaL2s3ivFGntg%3D%3D 3295589
17. P Brown M Preece JP Brandel, et al. 2000 Iatrogenic Creutzfeldt-Jakob disease at the millennium Neurology 55 1075 1081 1:STN:280: DC%2BD3crht12rsg%3D%3D 11071481
18. P Brown MA Preece RG Will 1992 "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease Lancet 340 24 27 1:STN:280:DyaK38zgtFWrug%3D%3D 1351607 10.1016/0140-6736(92)92431-E
19. H Budka 2003 Neuropathology of prion diseases Br Med Bull 66 121 130 1:CAS:528:DC%2BD3sXnvVeqsbw%3D 14522854 10.1093/bmb/66.1.121 (Pubitemid 37173497)
20. H Budka A Aguzzi P Brown, et al. 1995 Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases) Brain Pathol 5 459 466 1:STN:280: DyaK28vgtFOrtg%3D%3D 8974629 10.1111/j.1750-3639.1995.tb00625.x
21. I Cali R Castellani J Yuan, et al. 2006 Classification of sporadic Creutzfeldt-Jakob disease revisited Brain 129 2266 2277 16923954 10.1093/brain/awl224 (Pubitemid 44522113)
22. B Caughey GS Baron 2006 Prions and their partners in crime Nature 443 803 810 1:CAS:528:DC%2BD28XhtVyktbbI 17051207 10.1038/nature05294 (Pubitemid 44622685)
23. SG Chen P Parchi P Brown, et al. 1997 Allelic origin of the abnormal prion protein isoform in familial prion diseases Nat Med 3 1009 1015 1:CAS:528:DyaK2sXlvVylsrY%3D 9288728 10.1038/nm0997-1009 (Pubitemid 27391956)
24. JP Clewley CM Kelly N Andrews, et al. 2009 Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey BMJ 338 b1442 19460798 10.1136/bmj.b1442
25. J Collinge MS Palmer AJ Dryden 1991 Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease Lancet 337 1441 1442 1:STN:280:DyaK3M3mtVWqsw%3D%3D 1675319 10.1016/0140-6736(91)93128-V
26. J Collinge 1999 Variant Creutzfeldt-Jakob disease Lancet 354 317 323 1:STN:280:DyaK1Mzms12gtA%3D%3D 10440324 10.1016/S0140-6736(99)05128-4 (Pubitemid 29348751)
27. J Collinge 2001 Prion diseases of humans and animals: their causes and molecular basis Annu Rev Neurosci 24 519 550 1:CAS:528:DC%2BD3MXls1Shs7s%3D 11283320 10.1146/annurev.neuro.24.1.519 (Pubitemid 32695238)
28. J Collinge 2005 Molecular neurology of prion disease J Neurol Neurosurg Psychiatry 76 906 919 1:STN:280:DC%2BD2Mzhs1Clsw%3D%3D 15965195 10.1136/jnnp.2004.048660 (Pubitemid 40909547)
29. J Collinge J Brown J Hardy, et al. 1992 Inherited prion disease with 144 base pair gene insertion: II: Clinical and pathological features Brain 115 687 710 1352725 10.1093/brain/115.3.687
30. J Collinge A Clarke 2007 A general model of prion strains and their pathogenicity Science 318 930 936 1:CAS:528:DC%2BD2sXht1KhsLrF 17991853 10.1126/science.1138718 (Pubitemid 350098981)
31. J Collinge AE Harding F Owen, et al. 1989 Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis Lancet 2 15 17 1:STN:280:DyaL1M3psVOksg%3D%3D 2567794 10.1016/S0140-6736(89)90256-0
32. J Collinge F Owen M Poulter, et al. 1990 Prion dementia without characteristic pathology Lancet 336 7 9 1:STN:280:DyaK3czgvFGisQ%3D%3D 1973256 10.1016/0140-6736(90)91518-F (Pubitemid 20207867)
33. J Collinge MS Palmer KCL Sidle, et al. 1995 Unaltered susceptibility to BSE in transgenic mice expressing human prion protein Nature 378 779 783 1:CAS:528:DyaK28XltFSr 8524411 10.1038/378779a0
34. J Collinge KC Sidle J Meads J Ironside AF Hill 1996 Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD Nature 383 685 690 1:CAS:528:DyaK28XmsVGgu7Y%3D 8878476 10.1038/383685a0 (Pubitemid 26360638)
35. J Collinge J Whitfield E McKintosh, et al. 2006 Kuru in the 21st century-an acquired human prion disease with very long incubation periods Lancet 367 2068 2074 16798390 10.1016/S0140-6736(06)68930-7 (Pubitemid 43949290)
36. J Collinge J Whitfield E McKintosh, et al. 2008 A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea Philos Trans R Soc Lond B Biol Sci 363 3725 3739 18849289 10.1098/rstb.2008.0068
37. S Collins MG Law A Fletcher A Boyd J Kaldor CL Masters 1999 Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study Lancet 353 693 697 1:STN:280:DyaK1M7ntFGiug%3D%3D 10073510 10.1016/S0140- 6736(98)08138-0 (Pubitemid 29103801)
38. SJ Collins P Sanchez-Juan CL Masters, et al. 2006 Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease Brain 129 2278 2287 1:STN:280:DC%2BD28vpvVOksQ%3D%3D 16816392 10.1093/brain/awl159 (Pubitemid 44522114)
39. S Cronier N Gros MH Tattum, et al. 2008 Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin Biochem J 416 297 305 1:CAS:528:DC%2BD1cXhtlGls7fK 18684106 10.1042/BJ20081235
40. S Demart JG Fournier C Creminon, et al. 1999 New insight into abnormal prion protein using monoclonal antibodies Biochem Biophys Res Commun 265 652 657 1:CAS:528:DyaK1MXnvFaqtLY%3D 10600476 10.1006/bbrc.1999.1730
41. R Diaz-Avalos CY King J Wall M Simon DL Caspar 2005 Strain-specific morphologies of yeast prion amyloid fibrils Proc Natl Acad Sci USA 102 10165 10170 1:CAS:528:DC%2BD2MXmvVelurc%3D 16006506 10.1073/pnas.0504599102 (Pubitemid 41023343)
42. A Frosh LC Smith CJ Jackson, et al. 2004 Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein Lancet 364 1260 1262 15464187 10.1016/S0140-6736(04)17143-2 (Pubitemid 39311347)
43. R Gabizon G Telling Z Meiner M Halimi I Kahana SB Prusiner 1996 Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease Nat Med 2 59 64 1:CAS:528:DyaK28XivVSmsg%3D%3D 8564843 10.1038/nm0196-59 (Pubitemid 26028074)
44. P Gambetti Z Dong J Yuan, et al. 2008 A novel human disease with abnormal prion protein sensitive to protease Ann Neurol 63 697 708 1:CAS:528: DC%2BD1cXptFegurw%3D 18571782 10.1002/ana.21420 (Pubitemid 351945529)
45. P Gambetti Q Kong W Zou P Parchi SG Chen 2003 Sporadic and familial CJD: classification and characterisation Br Med Bull 66 213 239 1:CAS:528: DC%2BD3sXnvVeqtrk%3D 14522861 10.1093/bmb/66.1.213 (Pubitemid 37173504)
46. M Glatzel E Abela M Maissen A Aguzzi 2003 Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease N Engl J Med 349 1812 1820 1:CAS:528:DC%2BD3sXosl2gur8%3D 14602879 10.1056/NEJMoa030351 (Pubitemid 37362957)
47. JS Griffith 1967 Self replication and scrapie Nature 215 1043 1044 1:STN:280:DyaF1c%2Fht1amtw%3D%3D 4964084 10.1038/2151043a0
48. JA Hainfellner S Brantner-Inthaler L Cervenáková, et al. 1995 The original Gerstmann-Straussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype Brain Pathol 5 201 211 1:STN:280:DyaK28%2FkvVWmsg%3D%3D 8520719 10.1111/j.1750-3639.1995.tb00596.x
49. MW Head TJ Bunn MT Bishop, et al. 2004 Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: U.K. cases 1991-2002 Ann Neurol 55 851 859 1:CAS:528:DC%2BD2cXlsVCkurs%3D 15174020 10.1002/ana.20127 (Pubitemid 38702581)
50. MW Head JW Ironside 2006 Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein Brain 129 2238 2240 16923953 10.1093/brain/awl225 (Pubitemid 44522111)
51. MW Head D Ritchie N Smith, et al. 2004 Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study Am J Pathol 164 143 153 1:CAS:528:DC%2BD2cXlsVCgtw%3D%3D 14695328
52. AF Hill RJ Butterworth S Joiner, et al. 1999 Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples Lancet 353 183 189 1:STN:280:DyaK1M7itVOnug%3D%3D 9923873 10.1016/S0140-6736(98)12075-5 (Pubitemid 29088029)
53. AF Hill S Joiner J Beck, et al. 2006 Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations Brain 129 676 685 16415305 10.1093/brain/awl013 (Pubitemid 43278229)
54. AF Hill S Joiner JD Wadsworth, et al. 2003 Molecular classification of sporadic Creutzfeldt-Jakob disease Brain 126 1333 1346 12764055 10.1093/brain/awg125 (Pubitemid 36644379)
55. AF Hill M Zeidler J Ironside J Collinge 1997 Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy Lancet 349 99 100 1:STN:280:DyaK2s7kvFKitA%3D%3D 8996424 10.1016/S0140-6736(97)24002-X (Pubitemid 27023429)
56. DA Hilton AC Ghani L Conyers, et al. 2004 Prevalence of lymphoreticular prion protein accumulation in UK tissue samples J Pathol 203 733 739 1:CAS:528:DC%2BD2cXmtFSmt7o%3D 15221931 10.1002/path.1580 (Pubitemid 38961558)
57. DA Hilton J Sutak ME Smith, et al. 2004 Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease J Clin Pathol 57 300 302 1:CAS:528:DC%2BD2cXntVagu70%3D 14990604 10.1136/jcp.2003. 012278 (Pubitemid 38338845)
58. M Hizume A Kobayashi K Teruya, et al. 2009 Human prion protein (PrP) 219 K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection J Biol Chem 284 3603 3609 1:CAS:528:DC%2BD1MXht1OrtLk%3D 19074151 10.1074/jbc.M809254200
59. JW Ironside MW Head 2004 Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease Curr Top Microbiol Immunol 284 133 159 1:CAS:528:DC%2BD2cXlvFSiurs%3D 15148991
60. JW Ironside MW Head JE Bell L McCardle RG Will 2000 Laboratory diagnosis of variant Creutzfeldt-Jakob disease Histopathology 37 1 9 1:STN:280: DC%2BD3cvgsVWrsA%3D%3D 10931212 10.1046/j.1365-2559.2000.00946.x (Pubitemid 30496729)
61. S Joiner J Linehan S Brandner JD Wadsworth J Collinge 2005 High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease Gut 54 1506 1508 1:STN:280:DC%2BD2Mvpt1Shsg%3D%3D 16162963 10.1136/gut.2005. 072447 (Pubitemid 41375217)
62. CY King R Diaz-Avalos 2004 Protein-only transmission of three yeast prion strains Nature 428 319 323 1:CAS:528:DC%2BD2cXitFCnuro%3D 15029195 10.1038/nature02391 (Pubitemid 38418802)
63. Q Kong S Huang W Zou, et al. 2005 Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models J Neurosci 25 7944 7949 1:CAS:528:DC%2BD2MXhtVaktrfO 16135751 10.1523/JNEUROSCI.2467-05.2005 (Pubitemid 41254397)
64. C Korth K Kaneko D Groth, et al. 2003 Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene Proc Natl Acad Sci USA 100 4784 4789 1:CAS:528:DC%2BD3sXjt12nsbw%3D 12684540 10.1073/pnas.2627989100 (Pubitemid 36457806)
65. GG Kovacs G Trabattoni JA Hainfellner JW Ironside RS Knight H Budka 2002 Mutations of the prion protein gene phenotypic spectrum J Neurol 249 1567 1582 1:CAS:528:DC%2BD38Xps1Oltbc%3D 12420099 10.1007/s00415-002-0896-9 (Pubitemid 35477900)
66. R Krishnan SL Lindquist 2005 Structural insights into a yeast prion illuminate nucleation and strain diversity Nature 435 765 772 1:CAS:528:DC%2BD2MXkvVGgsLk%3D 15944694 10.1038/nature03679 (Pubitemid 40839721)
67. CI Lasmezas JG Fournier V Nouvel, et al. 2001 Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health Proc Natl Acad Sci USA 98 4142 4147 1:CAS:528:DC%2BD3MXis1KhtL0%3D 11259641 10.1073/pnas.041490898 (Pubitemid 32249912)
68. HS Lee P Brown L Cervenáková, et al. 2001 Increased susceptibility to kuru of carriers of the PRNP 129 methionine/methionine genotype J Infect Dis 183 192 196 1:CAS:528:DC%2BD3MXmsFGktA%3D%3D 11120925 10.1086/317935 (Pubitemid 32066018)
69. V Lewis AF Hill GM Klug A Boyd CL Masters SJ Collins 2005 Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles Neurology 65 113 118 1:STN:280:DC%2BD2Mzls1ertQ%3D%3D 16009895 10.1212/01.wnl.0000167188.65787.a0 (Pubitemid 40967785)
70. J Li S Browning SP Mahal AM Oelschlegel C Weissmann 2010 Darwinian evolution of prions in cell culture Science 327 869 872 1:CAS:528: DC%2BC3cXhslWis78%3D 20044542 10.1126/science.1183218
71. CA Llewelyn PE Hewitt RS Knight, et al. 2004 Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 417 421 1:STN:280:DC%2BD2c%2FnsVWhuw%3D%3D 14962520 10.1016/S0140-6736(04)15486-X (Pubitemid 38210057)
72. S Lloyd J Collinge 2005 Genetic susceptibility to prion diseases in humans and mice Current Genomics 6 1 11 1:CAS:528:DC%2BD2MXisVWgt7w%3D 10.2174/1389202053202166 (Pubitemid 40403363)
73. S Lloyd ON Onwuazor J Beck, et al. 2001 Identification of multiple quantitative trait loci linked to prion disease incubation period in mice Proc Natl Acad Sci USA 98 6279 6283 1:CAS:528:DC%2BD3MXktVWksLk%3D 11353827 10.1073/pnas.101130398 (Pubitemid 32488230)
74. SE Lloyd EG Maytham H Pota, et al. 2009 HECTD2 is associated with susceptibility to mouse and human prion disease PLoS Genet 5 e1000383 19214206 10.1371/journal.pgen.1000383 1:CAS:528:DC%2BD1MXisFygt7g%3D
75. I Mahillo-Fernandez J Pedro-Cuesta MJ Bleda, et al. 2008 Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies Neuroepidemiology 31 229 240 18843192 10.1159/000163097
76. S Mallik W Yang EM Norstrom JA Mastrianni 2010 Live cell FRET predicts an altered molecular association of heterologous PrP-Sc with PrP-C J Biol Chem 285 8967 8975 1:CAS:528:DC%2BC3cXjtFShtr8%3D 20086009 10.1074/jbc.M109.058107
77. S Mead M Poulter J Beck, et al. 2006 Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity Brain 129 2297 2317 16923955 10.1093/brain/awl226 (Pubitemid 44522116)
78. S Mead TE Webb TA Campbell, et al. 2007 Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129 Neurology 69 730 738 1:CAS:528:DC%2BD2sXovFWju7g%3D 17709704 10.1212/01.wnl.0000267642.41594.9d (Pubitemid 47300929)
79. S Mead MP Stumpf J Whitfield, et al. 2003 Balancing selection at the prion protein gene consistent with prehistoric kuru-like epidemics Science 300 640 643 1:CAS:528:DC%2BD3sXjtVymu7s%3D 12690204 10.1126/science.1083320 (Pubitemid 36520588)
80. S Mead 2006 Prion disease genetics Eur J Hum Genet 14 273 281 1:CAS:528:DC%2BD28Xhs1eqsbc%3D 16391566 10.1038/sj.ejhg.5201544
81. S Mead M Poulter J Uphill, et al. 2009 Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study Lancet Neurol 8 57 66 19081515 10.1016/S1474-4422(08)70265-5
82. G Miller 2009 Neurodegeneration. Could they all be prion diseases? Science 326 1337 1339 1:CAS:528:DC%2BD1MXhsFOhu7jK 19965731 10.1126/science.326. 5958.1337
83. KE Nazor F Kuhn T Seward, et al. 2005 Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice EMBO J 24 2472 2480 1:CAS:528:DC%2BD2MXlvVWqtrg%3D 15962001 10.1038/sj.emboj. 7600717 (Pubitemid 41032597)
84. S Notari S Capellari A Giese, et al. 2004 Effects of different experimental conditions on the PrPSc core generated by protease digestion: Implications for strain typing and molecular classification of CJD J Biol Chem 279 16797 16804 1:CAS:528:DC%2BD2cXjtVSjsr8%3D 14754888 10.1074/jbc.M313220200 (Pubitemid 38509382)
85. CW Olanow SB Prusiner 2009 Is Parkinson's disease a prion disorder? Proc Natl Acad Sci USA 106 12571 12572 1:CAS:528:DC%2BD1MXhtVKrurnJ 19666621 10.1073/pnas.0906759106
86. MS Palmer AJ Dryden JT Hughes J Collinge 1991 Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease Nature 352 340 342 1:CAS:528:DyaK3MXltFWrt7w%3D 1677164 10.1038/352340a0
87. P Parchi S Capellari SG Chen, et al. 1997 Typing prion isoforms Nature 386 232 233 1:CAS:528:DyaK2sXitVGktbc%3D 9069279 10.1038/386232a0 (Pubitemid 27142500)
88. P Parchi R Castellani S Capellari, et al. 1996 Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease Ann Neurol 39 767 778 1:CAS:528:DyaK28Xkt1Omsb0%3D 8651649 10.1002/ana.410390613 (Pubitemid 26183813)
89. P Parchi SG Chen P Brown, et al. 1998 Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease Proc Natl Acad Sci USA 95 8322 8327 1:CAS:528:DyaK1cXks1Sksbc%3D 9653185 10.1073/pnas.95.14.8322 (Pubitemid 28326111)
90. P Parchi A Giese S Capellari, et al. 1999 Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects Ann Neurol 46 224 233 1:STN:280:DyaK1MzntFCrug%3D%3D 10443888 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W (Pubitemid 29382879)
91. P Parchi S Notari P Weber, et al. 2008 Inter-laboratory assessment of PrP(Sc) typing in Creutzfeldt-Jakob disease: a western blot study within the NeuroPrion consortium Brain Pathol 19 384 391 18624793 10.1111/j.1750-3639.2008. 00187.x 1:CAS:528:DC%2BD1MXos1Ojtrs%3D
92. P Parchi WQ Zou W Wang, et al. 2000 Genetic influence on the structural variations of the abnormal prion protein Proc Natl Acad Sci USA 97 10168 10172 1:CAS:528:DC%2BD3cXmtlehtrg%3D 10963679 10.1073/pnas.97.18.10168
93. AH Peden MW Head DL Ritchie JE Bell JW Ironside 2004 Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient Lancet 364 527 529 15302196 10.1016/S0140-6736(04)16811-6 (Pubitemid 39070413)
94. AH Peden DL Ritchie MW Head JW Ironside 2006 Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease Am J Pathol 168 927 935 1:CAS:528:DC%2BD28XislGgur8%3D 16507908 10.2353/ajpath.2006.050788 (Pubitemid 43327745)
95. Pedro-Cuesta J, Mahillo-Fernandez I, Rabano A et al (2010) Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry (in press)
96. P Piccardo SR Dlouhy PMJ Lievens, et al. 1998 Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity J Neuropathol Exp Neurol 57 979 988 1:STN:280: DyaK1M%2FgtVWrtQ%3D%3D 9786248 10.1097/00005072-199810000-00010
97. P Piccardo JJ Liepnieks A William, et al. 2001 Prion proteins with different conformations accumulate in Gerstmann-Straussler-Scheinker disease caused by A117V and F198S mutations Am J Pathol 158 2201 2207 1:CAS:528:DC%2BD3MXkvFyktrw%3D 11395398
98. M Polymenidou K Stoeck M Glatzel M Vey A Bellon A Aguzzi 2005 Coexistence of multiple PrP(Sc) types in individuals with Creutzfeldt-Jakob disease Lancet Neurol 4 805 814 1:CAS:528:DC%2BD2MXhtlWmtrjI 16297838 10.1016/S1474-4422(05) 70225-8 (Pubitemid 41619435)
99. SB Prusiner 1982 Novel proteinaceous infectious particles cause scrapie Science 216 136 144 1:CAS:528:DyaL38XhsFyqtro%3D 6801762 10.1126/science.6801762
100. SB Prusiner 1998 Prions Proc Natl Acad Sci USA 95 13363 13383 1:CAS:528:DyaK1cXnsVGhsbY%3D 9811807 10.1073/pnas.95.23.13363 (Pubitemid 28525623)
101. Sc in the same brain Neurology 53 2173 2176 1:STN:280: DC%2BD3c%2Fms1OrsQ%3D%3D 10599800
102. D Riesner 2003 Biochemistry and structure of PrP(C) and PrP(Sc) Br Med Bull 66 21 33 1:CAS:528:DC%2BD3sXnvVeqtr4%3D 14522846 10.1093/bmb/66.1.21 (Pubitemid 37173489)
103. Sc molecules with different conformations Nat Med 4 1157 1165 1:CAS:528:DyaK1cXms1Ggt74%3D 9771749 10.1038/2654 (Pubitemid 28468829)
104. JG Safar MD Geschwind C Deering, et al. 2005 Diagnosis of human prion disease Proc Natl Acad Sci USA 102 3501 3506 1:CAS:528:DC%2BD2MXitl2ksrs%3D 15741275 10.1073/pnas.0409651102 (Pubitemid 40328074)
105. G Schoch H Seeger J Bogousslavsky, et al. 2005 Analysis of prion strains by PrP(Sc) profiling in sporadic Creutzfeldt-Jakob disease PLoS Med 3 e14 16354106 10.1371/journal.pmed.0030014 1:CAS:528:DC%2BD28XitlKiu74%3D
106. J Shorter S Lindquist 2005 Prions as adaptive conduits of memory and inheritance Nat Rev Genet 6 435 450 1:CAS:528:DC%2BD2MXkslSnu7s%3D 15931169 10.1038/nrg1616 (Pubitemid 40733889)
107. JR Silveira GJ Raymond AG Hughson, et al. 2005 The most infectious prion protein particles Nature 437 257 261 1:CAS:528:DC%2BD2MXpsleku74%3D 16148934 10.1038/nature03989 (Pubitemid 41294488)
108. MC Silvestrini F Cardone B Maras, et al. 1997 Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients Nat Med 3 521 525 1:CAS:528: DyaK2sXivFOms7w%3D 9142120 10.1038/nm0597-521
109. DA Stephenson K Chiotti C Ebeling, et al. 2000 Quantitative trait loci affecting prion incubation time in mice Genomics 69 47 53 1:CAS:528: DC%2BD3cXmvFWlurw%3D 11013074 10.1006/geno.2000.6320
110. F Tagliavini PMJ Lievens C Tranchant, et al. 2001 A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V J Biol Chem 276 6009 6015 1:CAS:528:DC%2BD3MXhs1Kmuro%3D 11087738 10.1074/jbc.M007062200
111. M Tanaka P Chien N Naber R Cooke JS Weissman 2004 Conformational variations in an infectious protein determine prion strain differences Nature 428 323 328 1:CAS:528:DC%2BD2cXitFCnurs%3D 15029196 10.1038/nature02392 (Pubitemid 38418803)
112. M Tanaka P Chien K Yonekura JS Weissman 2005 Mechanism of cross-species prion transmission an infectious conformation compatible with two highly divergent yeast prion proteins Cell 121 49 62 1:CAS:528:DC%2BD2MXjsVaks7k%3D 15820678 10.1016/j.cell.2005.03.008
113. GC Telling P Parchi SJ DeArmond, et al. 1996 Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity Science 274 2079 2082 1:CAS:528:DyaK2sXjtFeq 8953038 10.1126/science.274.5295.2079 (Pubitemid 27020700)
114. GC Telling M Scott J Mastrianni, et al. 1995 Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein Cell 83 79 90 1:CAS:528:DyaK2MXosF2ku7g%3D 7553876 10.1016/0092-8674(95)90236-8
115. AM Thackray L Hopkins R Bujdoso 2007 Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay Biochem J 401 475 483 1:CAS:528:DC%2BD2sXhtVahtQ%3D%3D 17018021 10.1042/BJ20061264 (Pubitemid 46166430)
116. P Tremblay HL Ball K Kaneko, et al. 2004 Mutant PrP(Sc) conformers induced by a synthetic peptide and several prion strains J Virol 78 2088 2099 1:CAS:528:DC%2BD2cXhtFKnsLo%3D 14747574 10.1128/JVI.78.4.2088-2099.2004 (Pubitemid 38176741)
117. S Tzaban G Friedlander O Schonberger, et al. 2002 Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes Biochemistry 41 12868 12875 1:CAS:528:DC%2BD38Xntlaisbg%3D 12379130 10.1021/bi025958g (Pubitemid 35192516)
118. E Uro-Coste H Cassard S Simon, et al. 2008 Beyond PrP type 1/type 2 dichotomy in Creutzfeldt-Jakob disease PLoS Pathog 4 e1000029 10.1371/journal.ppat.1000029 1:CAS:528:DC%2BD1cXksFelsbc%3D (Pubitemid 351631097)
119. JD Wadsworth EA Asante M Desbruslais, et al. 2004 Human prion protein with valine 129 prevents expression of variant CJD phenotype Science 306 1793 1796 1:CAS:528:DC%2BD2cXhtVKitb%2FN 15539564 10.1126/science.1103932 (Pubitemid 39601400)
120. JD Wadsworth J Collinge 2007 Update on human prion disease Biochim Biophys Acta 1772 598 609 1:CAS:528:DC%2BD2sXmtlWjurw%3D 17408929
121. JD Wadsworth AF Hill JA Beck J Collinge 2003 Molecular and clinical classification of human prion disease Br Med Bull 66 241 254 1:CAS:528:DC%2BD3sXnvVeqtrY%3D 14522862 10.1093/bmb/66.1.241 (Pubitemid 37173505)
122. JD Wadsworth AF Hill S Joiner GS Jackson A Clarke J Collinge 1999 Strain-specific prion-protein conformation determined by metal ions Nat Cell Biol 1 55 59 1:CAS:528:DyaK1MXksVKitrg%3D 10559865 10.1038/9030
123. JD Wadsworth S Joiner K Fox, et al. 2007 Prion infectivity in variant Creutzfeldt-Jakob disease rectum Gut 56 90 94 1:CAS:528:DC%2BD2sXhtF2qsLk%3D 16763054 10.1136/gut.2006.091637 (Pubitemid 46044893)
124. JD Wadsworth S Joiner AF Hill, et al. 2001 Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay Lancet 358 171 180 1:CAS:528:DC%2BD3MXltlymsr4%3D 11476832 10.1016/S0140-6736(01)05403-4 (Pubitemid 32718539)
125. JD Wadsworth S Joiner J Linehan, et al. 2006 Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein Brain 129 1557 1569 16597650 10.1093/brain/awl076 (Pubitemid 43999387)
126. JD Wadsworth S Joiner JM Linehan EA Asante S Brandner J Collinge 2008 Review. The origin of the prion agent of kuru: molecular and biological strain typing Philos Trans R Soc Lond B Biol Sci 363 3747 3753 1:CAS:528: DC%2BD1cXhsVGgt7jJ 18849291 10.1098/rstb.2008.0069
127. JD Wadsworth S Joiner JM Linehan, et al. 2008 Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice Proc Natl Acad Sci USA 105 3885 3890 1:CAS:528:DC%2BD1cXjs1Ohs7w%3D 18316717 10.1073/pnas.0800190105 (Pubitemid 351723494)
128. JD Wadsworth C Powell JA Beck, et al. 2008 Molecular diagnosis of human prion disease Methods Mol Biol 459 197 227 1:CAS:528:DC%2BD1cXosVSqtLg%3D 18576157 10.1007/978-1-59745-234-2-14
129. C Weissmann 2004 The state of the prion Nat Rev Microbiol 2 861 871 1:CAS:528:DC%2BD2cXos1Kqu78%3D 15494743 10.1038/nrmicro1025 (Pubitemid 39561804)
130. WM Wemheuer SL Benestad A Wrede, et al. 2009 Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types Am J Pathol 175 2566 2573 1:CAS:528:DC%2BC3cXkt12kuw%3D%3D 19850886 10.2353/ajpath.2009.090623
131. WHO (2003) WHO manual for surveillance of human transmissible spongiform encephalopathies. http://www.who.int/bloodproducts/TSE-manual2003.pdf
132. RB Wickner HK Edskes F Shewmaker T Nakayashiki 2007 Prions of fungi: inherited structures and biological roles Nat Rev Microbiol 5 611 618 1:CAS:528:DC%2BD2sXns12hurw%3D 17632572 10.1038/nrmicro1708 (Pubitemid 47074116)
133. RG Will 2003 Acquired prion disease: iatrogenic CJD, variant CJD, kuru Br Med Bull 66 255 265 1:CAS:528:DC%2BD3sXnvVeqtrc%3D 14522863 10.1093/bmb/66.1.255 (Pubitemid 37173506)
134. RG Will JW Ironside M Zeidler, et al. 1996 A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 921 925 1:STN:280: DyaK287nvVKruw%3D%3D 8598754 10.1016/S0140-6736(96)91412-9
135. O Windl M Dempster JP Estibeiro, et al. 1996 Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene Hum Genet 98 259 264 1:CAS:528:DyaK28Xls1Chu7w%3D 8707291 10.1007/s004390050204 (Pubitemid 26258371)
136. SJ Wroe S Pal D Siddique, et al. 2006 Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report Lancet 368 2061 2067 17161728 10.1016/S0140-6736(06) 69835-8 (Pubitemid 44855106)
137. HM Yull DL Ritchie JP Langeveld, et al. 2006 Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease Am J Pathol 168 151 157 1:CAS:528:DC%2BD28XhtVKksb0%3D 16400018 10.2353/ajpath.2006.050766 (Pubitemid 43062568)
138. G Zanusso A Farinazzo M Fiorini, et al. 2001 pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease J Biol Chem 276 40377 40380 1:CAS:528:DC%2BD3MXosVKhsbY%3D 11682490 10.1074/jbc.C100458200
139. G Zanusso A Farinazzo F Prelli, et al. 2004 Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes J Biol Chem 279 38936 38942 1:CAS:528:DC%2BD2cXnt1yjsL0%3D 15247220 10.1074/jbc.M405468200 (Pubitemid 39296054)